Abstract
Cubosomes are self-assembled nanostructures that often form on dispersion of polar lipids in aqueous environments. The nanoparticles are analogous to liposomes but contain a complex internal self-assembled structure providing a point of difference to relatively simple liposomes. They exhibit a range of attractive properties such as having a high surface area, being able to incorporate both hydrophobic and hydrophilic molecules and controlled release. Consequently cubosomes are of increasing interest in fields such as drug delivery, and diagnostic imaging, in particular as a carrier for magnetic resonance imaging contrast agents. Over the last decade the incorporation of various contrast agents into the cubic mesophases has demonstrated improved relaxivity and resolution, as well as addressing other limitations of commercially available agents by increasing circulation time, stability and targeting. This minireview provides a brief overview of what cubosomes are, how they can be made, how they are characterised and also summarise the findings from the studies that have used cubosomes to develop better contrast agents for MRI, as well as highlight some potential for future developments.
Keywords: Cubosomes, cubic phase, MRI, contrast agent, relaxivity, liquid crystalline, lipid.
Current Medicinal Chemistry
Title:Cubosomes as Carriers for MRI Contrast Agents
Volume: 24 Issue: 5
Author(s): Nicolas Alcaraz and Ben J. Boyd
Affiliation:
Keywords: Cubosomes, cubic phase, MRI, contrast agent, relaxivity, liquid crystalline, lipid.
Abstract: Cubosomes are self-assembled nanostructures that often form on dispersion of polar lipids in aqueous environments. The nanoparticles are analogous to liposomes but contain a complex internal self-assembled structure providing a point of difference to relatively simple liposomes. They exhibit a range of attractive properties such as having a high surface area, being able to incorporate both hydrophobic and hydrophilic molecules and controlled release. Consequently cubosomes are of increasing interest in fields such as drug delivery, and diagnostic imaging, in particular as a carrier for magnetic resonance imaging contrast agents. Over the last decade the incorporation of various contrast agents into the cubic mesophases has demonstrated improved relaxivity and resolution, as well as addressing other limitations of commercially available agents by increasing circulation time, stability and targeting. This minireview provides a brief overview of what cubosomes are, how they can be made, how they are characterised and also summarise the findings from the studies that have used cubosomes to develop better contrast agents for MRI, as well as highlight some potential for future developments.
Export Options
About this article
Cite this article as:
Alcaraz Nicolas and Boyd J. Ben, Cubosomes as Carriers for MRI Contrast Agents, Current Medicinal Chemistry 2017; 24 (5) . https://dx.doi.org/10.2174/0929867323666160817141556
DOI https://dx.doi.org/10.2174/0929867323666160817141556 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Leukocyte-mediated Tissue Injury in Ischemic Stroke
Current Medicinal Chemistry Fructose 1,6-Bisphosphate: A Summary of Its Cytoprotective Mechanism
Current Medicinal Chemistry Induced Adaptive Resistance to Nitrooxidative Stress in the CNS: Therapeutic Implications
Central Nervous System Agents in Medicinal Chemistry The Role of Pericytes in Blood-Brain Barrier Function and Stroke
Current Pharmaceutical Design Cardiac Dysfunction in Rats with Dietary-Induced Insulin Resistance Associated with Pharmacologically-induced Dyslipidemia
Current Pharmaceutical Design The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Novel Anti-Platelets in Stable Coronary Artery Disease
Current Pharmaceutical Design Mixed Connective Tissue Disease (MCTD) – A Coming of Age
Current Rheumatology Reviews Redox Chemistry of Green Tea Polyphenols: Therapeutic Benefits in Neurodegenerative Diseases
Mini-Reviews in Medicinal Chemistry Targeting Mitochondrial Oxidative Stress Through Lipoic Acid Synthase: A Novel Strategy to Manage Diabetic Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Mineralocorticoid Receptor Blockade in the Protection of Target Organ Damage
Cardiovascular & Hematological Agents in Medicinal Chemistry Endothelial Progenitor Cells in Prehypertension
Current Pharmaceutical Design Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity?
CNS & Neurological Disorders - Drug Targets What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design Neuropharmacology of Vestibular System Disorders
Current Neuropharmacology Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?
Current Cancer Drug Targets Biological and Pharmacological Activities of Carvacrol and Carvacrol Bearing Essential Oils
Current Pharmaceutical Design microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia
Current Vascular Pharmacology Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview
Current Protein & Peptide Science